• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过增强分泌鉴定负责高水平表达的猪凝血因子VIII结构域。

Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.

作者信息

Doering Christopher B, Healey John F, Parker Ernest T, Barrow Rachel T, Lollar Pete

机构信息

Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.

出版信息

J Biol Chem. 2004 Feb 20;279(8):6546-52. doi: 10.1074/jbc.M312451200. Epub 2003 Dec 1.

DOI:10.1074/jbc.M312451200
PMID:14660593
Abstract

Blood coagulation factor VIII has a domain structure designated A1-A2-B-ap-A3-C1-C2. Human factor VIII is present at low concentration in normal plasma and, comparably, is produced at low levels in vitro and in vivo using transgenic expression techniques. Heterologous expression of B domain-deleted porcine factor VIII in mammalian cell culture is significantly greater than B domain-deleted human or murine factor VIII. Novel hybrid human/porcine factor VIII molecules were constructed to identify porcine factor VIII domains that confer high level expression. Hybrid human/porcine factor VIII constructs containing the porcine factor VIII A1 and ap-A3 domains expressed at levels comparable with recombinant porcine factor VIII. A hybrid construct containing only the porcine A1 domain expressed at intermediate levels between human and porcine factor VIII, whereas a hybrid construct containing the porcine ap-A3 domain expressed at levels comparable with human factor VIII. Additionally, hybrid murine/porcine factor VIII constructs containing the porcine factor VIII A1 and ap-A3 domain sequences expressed at levels significantly higher than recombinant murine factor VIII. Therefore, the porcine A1 and ap-A3 domains are necessary and sufficient for the high level expression associated with porcine factor VIII. Metabolic radiolabeling experiments demonstrated that high level expression was attributable to enhanced secretory efficiency.

摘要

血液凝固因子VIII具有名为A1 - A2 - B - ap - A3 - C1 - C2的结构域结构。人因子VIII在正常血浆中的浓度较低,同样,使用转基因表达技术在体外和体内的产量也很低。在哺乳动物细胞培养中,缺失B结构域的猪因子VIII的异源表达显著高于缺失B结构域的人或鼠因子VIII。构建了新型人/猪杂交因子VIII分子,以鉴定赋予高水平表达的猪因子VIII结构域。含有猪因子VIII A1和ap - A3结构域的人/猪杂交因子VIII构建体的表达水平与重组猪因子VIII相当。仅含有猪A1结构域的杂交构建体的表达水平介于人和猪因子VIII之间,而含有猪ap - A3结构域的杂交构建体的表达水平与人因子VIII相当。此外,含有猪因子VIII A1和ap - A3结构域序列的鼠/猪杂交因子VIII构建体的表达水平显著高于重组鼠因子VIII。因此,猪A1和ap - A3结构域对于与猪因子VIII相关的高水平表达是必要且充分的。代谢放射性标记实验表明,高水平表达归因于分泌效率的提高。

相似文献

1
Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.通过增强分泌鉴定负责高水平表达的猪凝血因子VIII结构域。
J Biol Chem. 2004 Feb 20;279(8):6546-52. doi: 10.1074/jbc.M312451200. Epub 2003 Dec 1.
2
Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.使用多重取代的人/猪杂交因子VIII分子降低因子VIII对复合抑制性抗体血浆的抗原性。
Blood. 2000 Jan 15;95(2):564-8.
3
A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.凝血因子 VIII 的 A1 结构域内一个 110 个氨基酸的区域可抑制哺乳动物细胞的分泌。
J Biol Chem. 1995 Apr 28;270(17):10297-303. doi: 10.1074/jbc.270.17.10297.
4
High level expression of recombinant porcine coagulation factor VIII.重组猪凝血因子VIII的高水平表达。
J Biol Chem. 2002 Oct 11;277(41):38345-9. doi: 10.1074/jbc.M206959200. Epub 2002 Jul 23.
5
Role of the B domain for factor VIII and factor V expression and function.B结构域对凝血因子VIII和凝血因子V表达及功能的作用。
Blood. 1994 Dec 15;84(12):4214-25.
6
[Enhancing effect of porcine coagulation factor VIII A1 and A3 domains on secretion of post-translationally spliced human/porcine hybrid coagulation factor VIII].[猪凝血因子VIII A1和A3结构域对翻译后剪接的人/猪杂交凝血因子VIII分泌的增强作用]
Sheng Li Xue Bao. 2010 Aug 25;62(4):373-81.
7
Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIII.异源因子V重链序列对重组人凝血因子VIII分泌的影响。
Thromb Haemost. 1996 Jan;75(1):36-44.
8
Coagulant properties of hybrid human/porcine factor VIII molecules.人/猪杂交因子VIII分子的凝血特性
J Biol Chem. 1992 Nov 25;267(33):23652-7.
9
Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.与猪源同源物相比,人凝血因子VIII促凝活性降低的结构基础。
J Biol Chem. 1991 Jul 5;266(19):12481-6.
10
The cDNA and derived amino acid sequence of porcine factor VIII.猪凝血因子VIII的cDNA及推导的氨基酸序列。
Blood. 1996 Dec 1;88(11):4209-14.

引用本文的文献

1
lentiviral gene therapy for severe hemophilia A: an alternative to recombinant adeno-associated viral-based strategies?用于重度甲型血友病的慢病毒基因治疗:基于重组腺相关病毒策略的替代方法?
Res Pract Thromb Haemost. 2025 Mar 20;9(2):102716. doi: 10.1016/j.rpth.2025.102716. eCollection 2025 Feb.
2
A Comparative Review on the Production of Factor VIII in Human and Non-human Hosts.人类和非人类宿主中因子VIII产生的比较综述。
Curr Pharm Des. 2025;31(18):1417-1429. doi: 10.2174/0113816128327353241121050134.
3
Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.
采用CD34+造血细胞的慢病毒基因疗法治疗甲型血友病
N Engl J Med. 2025 Jan 30;392(5):450-457. doi: 10.1056/NEJMoa2410597. Epub 2024 Dec 9.
4
Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces.模拟活化血小板表面的脂质纳米盘结合凝血因子VIII的生物物理特性研究
J Thromb Haemost. 2025 Feb;23(2):513-524. doi: 10.1016/j.jtha.2024.11.003. Epub 2024 Nov 15.
5
Sequence-encoded bioactive protein-multiblock polymer conjugates via quantitative one-pot iterative living polymerization.通过定量一锅迭代活性聚合制备序列编码的生物活性蛋白-多嵌段聚合物缀合物。
Nat Commun. 2024 Aug 7;15(1):6729. doi: 10.1038/s41467-024-51122-1.
6
Coagulation factor VIII: biological basis of emerging hemophilia A therapies.凝血因子 VIII:新兴血友病 A 治疗方法的生物学基础。
Blood. 2024 Nov 21;144(21):2185-2197. doi: 10.1182/blood.2023023275.
7
Cellular stress and coagulation factor production: when more is not necessarily better.细胞应激与凝血因子生成:过犹不及。
J Thromb Haemost. 2023 Dec;21(12):3329-3341. doi: 10.1016/j.jtha.2023.10.005. Epub 2023 Oct 14.
8
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor.凝血因子 VIII 与患者来源的抗 C1 结构域抗体抑制剂复合物的结构。
Blood. 2023 Jul 13;142(2):197-201. doi: 10.1182/blood.2023020181.
9
Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.比较不同的基因添加策略,以修饰胎盘来源的间充质基质细胞来产生 FVIII。
Front Immunol. 2022 Dec 15;13:954984. doi: 10.3389/fimmu.2022.954984. eCollection 2022.
10
Subunit Flexibility of Multimeric von Willebrand Factor/Factor VIII Complexes.多聚体血管性血友病因子/凝血因子VIII复合物的亚基灵活性
ACS Omega. 2022 Aug 25;7(35):31183-31196. doi: 10.1021/acsomega.2c03389. eCollection 2022 Sep 6.